AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,574,302 | +20.0% | 7,521,317 | -3.7% | 0.00% | – |
| Q2 2023 | $7,147,121 | +1.9% | 7,811,061 | -37.6% | 0.00% | – |
| Q1 2023 | $7,011,110 | +8.1% | 12,510,904 | +11.3% | 0.00% | – |
| Q4 2022 | $6,484,828 | +55.6% | 11,238,870 | -14.7% | 0.00% | – |
| Q3 2022 | $4,168,000 | -27.4% | 13,182,865 | -18.9% | 0.00% | – |
| Q2 2022 | $5,741,000 | -44.5% | 16,259,104 | +12.9% | 0.00% | – |
| Q1 2022 | $10,339,000 | -65.4% | 14,402,988 | +8.8% | 0.00% | -100.0% |
| Q4 2021 | $29,914,000 | -16.3% | 13,235,669 | +6.6% | 0.00% | 0.0% |
| Q3 2021 | $35,745,000 | -22.4% | 12,411,243 | +2.1% | 0.00% | 0.0% |
| Q2 2021 | $46,071,000 | +16.4% | 12,155,719 | +4.0% | 0.00% | 0.0% |
| Q1 2021 | $39,577,000 | +67.6% | 11,692,154 | +38.6% | 0.00% | 0.0% |
| Q4 2020 | $23,617,000 | +43.3% | 8,434,759 | +28.5% | 0.00% | 0.0% |
| Q3 2020 | $16,478,000 | -83.4% | 6,565,065 | -10.3% | 0.00% | -75.0% |
| Q2 2020 | $99,417,000 | +122.8% | 7,320,876 | +24.4% | 0.00% | +100.0% |
| Q1 2020 | $44,613,000 | +27.9% | 5,885,554 | +6.6% | 0.00% | +100.0% |
| Q4 2019 | $34,888,000 | +62.8% | 5,520,180 | +1.0% | 0.00% | 0.0% |
| Q3 2019 | $21,427,000 | -14.4% | 5,466,057 | +5.7% | 0.00% | 0.0% |
| Q2 2019 | $25,023,000 | -47.4% | 5,169,931 | -10.9% | 0.00% | -50.0% |
| Q1 2019 | $47,528,000 | +75.1% | 5,803,369 | +18.3% | 0.00% | +100.0% |
| Q4 2018 | $27,138,000 | +20.2% | 4,907,351 | +91.9% | 0.00% | 0.0% |
| Q3 2018 | $22,583,000 | -12.1% | 2,557,583 | -0.7% | 0.00% | 0.0% |
| Q2 2018 | $25,702,000 | +14.3% | 2,575,354 | +9.2% | 0.00% | 0.0% |
| Q1 2018 | $22,482,000 | -22.1% | 2,359,189 | +21.5% | 0.00% | 0.0% |
| Q4 2017 | $28,866,000 | -14.7% | 1,941,202 | +12.8% | 0.00% | -50.0% |
| Q3 2017 | $33,852,000 | +64.0% | 1,721,018 | +19.8% | 0.00% | +100.0% |
| Q2 2017 | $20,638,000 | +72.3% | 1,436,163 | +10.3% | 0.00% | 0.0% |
| Q1 2017 | $11,977,000 | -3.8% | 1,301,880 | +8.8% | 0.00% | 0.0% |
| Q4 2016 | $12,453,000 | +19.4% | 1,196,235 | +3.8% | 0.00% | 0.0% |
| Q3 2016 | $10,430,000 | +28.5% | 1,152,463 | +6.2% | 0.00% | 0.0% |
| Q2 2016 | $8,118,000 | -11.5% | 1,085,393 | +6.6% | 0.00% | 0.0% |
| Q1 2016 | $9,173,000 | +3.0% | 1,018,147 | +47.7% | 0.00% | 0.0% |
| Q4 2015 | $8,905,000 | -95.5% | 689,282 | -88.3% | 0.00% | -85.7% |
| Q3 2015 | $197,565,000 | +3789.8% | 5,886,112 | +1092.4% | 0.01% | – |
| Q2 2015 | $5,079,000 | +58.8% | 493,629 | +71.5% | 0.00% | – |
| Q1 2015 | $3,198,000 | +18.8% | 287,842 | +24.4% | 0.00% | – |
| Q4 2014 | $2,693,000 | -25.8% | 231,325 | +41.0% | 0.00% | – |
| Q3 2014 | $3,631,000 | -11.7% | 164,111 | +11.0% | 0.00% | – |
| Q2 2014 | $4,110,000 | – | 147,874 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |